# A.M.I. Agency for Medical Innovations GmbH: Not applicable (device, behavioral) study started recruiting, 100 planned (Pelvic Organ Prolapse (POP), Synthetic Mesh)

**Score:** 90/100

| Field | Value |
|---|---|
| Sponsor | A.M.I. Agency for Medical Innovations GmbH |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious) |
| NCT ID | NCT07497321 |
| Phase | Not applicable (device, behavioral) |
| Status | recruiting |
| Conditions | Pelvic Organ Prolapse (POP); Synthetic Mesh; Laparoscopic Surgery; Gynecologic Laparoscopic Surgery; Sacrocolpopexy; Pelvic Floor Prolapse |
| Intervention types | device |
| Target enrollment | 100 |
| Site countries | Austria, Germany |
| Posted | 2026-03-27 |
| Planned start | 2026-10-28 |
| Event | Started recruiting |
| Event date | 2026-10-28 |
| Last update posted | 2026-10-30 |

## Why this score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Just started recruiting: sites, recruitment and supply are active.
- 100 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07497321). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.